Pterosin B
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Pterosin B
Description:
Pterosin B is an orally active indanone. Pterosin B can be obtained from Pteridium aquilinum. Pterosin B is a Sik3 signaling inhibitor. Pterosin B inhibits Klf5 expression and reduces β-amyloid deposition. Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice. Pterosin B inhibits cardiomyocyte hypertrophy, improves cognitive impairment, and lowers blood glucose. Pterosin B can be used in research on arthritis, Alzheimer's disease, pathological cardiac hypertrophy and diabetes[1][2][3][4][5].UNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
Amyloid-β; KLF; Salt-inducible Kinase (SIK)Type:
Natural ProductsRelated Pathways:
Immunology/Inflammation; MAPK/ERK Pathway; Neuronal SignalingApplications:
COVID-19-immunoregulationField of Research:
Endocrinology; Metabolic Disease; Inflammation/Immunology; Neurological Disease; Cardiovascular DiseaseAssay Protocol:
https://www.medchemexpress.com/pterosin-b.htmlPurity:
99.98Solubility:
DMSO : 250 mg/mL (ultrasonic)Smiles:
O=C1[C@H] (C) CC2=C1C (C) =C (CCO) C (C) =C2Molecular Formula:
C14H18O2Molecular Weight:
218.30Precautions:
H302, H315, H319, H335References & Citations:
[1]Hannah R.Dexter, et al. A concise stereoselective synthesis of pterosin B. Tetrahedron Letters, Volume 59, Issue 49, 5 December 2018, Pages 4323-4325.|[2]Yahara Y, et al. Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3. Nat Commun. 2016 Mar 24;7:10959.|[3]Lee C Y, et al. Novel therapeutic effects of pterosin B on Ang II-induced cardiomyocyte hypertrophy. Molecules, 2020, 25 (22) : 5279.|[4]Zhang Y, et al. Pterosin B improves cognitive dysfunction by promoting microglia M1/M2 polarization through inhibiting Klf5/Parp14 pathway. Phytomedicine. 2024 Dec;135:156152.|[5]Itoh Y. Pterosin B, ingredient in Pteridium aquilinum, regulates hepatic gluconeogenesis via SIK3-dependent and independent mechanisms. 2017.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedIsoform:
SIK3CAS Number:
34175-96-7
